Check in often for a current list of national research funding opportunities with upcoming deadlines.

Directory


Ongoing

A-T Children’s Project – Research Grant Program
  • Due: LOI submission rolling
  • Funding: Up to $75,000 per year
  • Project period:  1 to 2 years
  • Purpose: To support translational and clinical research grants for research related to ataxia-telangiectasia including disease-modifying strategies that would prevent, slow, or stop the progression of the disease, symptom-improving strategies that address neural circuit function, immune system health and lung function, especially the neurological symptoms.
  • Eligibility: Investigators at all levels eligible to apply. Early career scientists are particularly encouraged to apply.
Cystic Fibrosis FoundationPath to a Cure: Industry Award with LOI
  • Due: LOI submission rolling
  • Funding: Negotiable
  • Project period:  Not specified
  • Purpose: To support development of treatments for the underlying cause of the disease and, ultimately, a cure for CF.
  • Eligibility: Matching funding required. U.S.-based and non U.S.-based research and development focused companies welcome to apply. Milestone completion and subsequent funding requirement.
Cystic Fibrosis FoundationStudent Loan Repayment Program
  • Due: During and up to 4 months after active award period
  • Funding: $14,000 per year maximum
  • Project period: One-time payment
  • Purpose: To assist with repayment of educational loan debt associated with a graduate-level degree.
  • Eligibility: Applicants must be current awardees of one of the following CFF programs: 1. First through fifth Year Clinical Fellows, 2. Harry Shwachman CF Clinical Investigator, 3. LeRoy Matthews Physician-Scientist, 4. Envision CF: Emerging Leaders in CF Endocrinology II Program, and 5. Developing Innovative Gastroenterology Specialty Training (DIGEST) Program. Other eligibility requirements may apply.
Gateway for Cancer Research GFCR Grant Program
  • Due: Rolling; July 26, 2022 next cycle (LOI)
  • Funding: $200,000 to $1.5 M
  • Project period: 2 to 5 years
  • Purpose: To fund early phase clinical trials for all types of cancers.
  • Eligibility: Funds are awarded to institutions. Applicants must demonstrate that their project aligns with GFCR’s mission.
  • Note: LOIs are accepted on a rolling basis. Submit LOI prior to deadline for this cycle.
Gateway for Cancer Research SIO Integrative Program
  • Due: Rolling; July 26, 2022 next cycle (LOI)
  • Funding: $200,000 to $1.5 M
  • Project period: 2 to 5 years
  • Purpose: To fund integrative oncology research that pairs conventional therapies with evidence-based integrative therapies to manage symptoms and side effects from treatment and increase quality of life, especially post-treatment.
  • Eligibility: Applicants must demonstrate that their project aligns with GFCR’s mission.
  • Note: LOIs are accepted on a rolling basis. Submit LOI prior to deadline for this cycle.
Gateway for Cancer ResearchNCI/SPORE Program
  • Due: Rolling; July 26, 2022 next cycle (LOI)
  • Funding: $200,000 to $800,000
  • Project period: 2 to 5 years
  • Purpose: A partnership with the NCI to give SPORE recipients a chance to apply for supplemental funding for their early phase, innovative clinical trials and enable principal investigators and their respective institutions to start a new trial through an additional arm, add patient cohorts and/or new correlative analysis. 
  • Eligibility: Applicants must demonstrate that their project aligns with GFCR’s mission.
  • Note: LOIs are accepted on a rolling basis. Submit LOI prior to deadline for this cycle.
Pfizer Global Medical Grants – Independent Medical Education Grant RFP: Local Level Educational Grants Program to Increase Awareness & Understanding of Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
  • Due: Rolling: July 29 next due date
  • Funding: Up to $20,000
  • Project period: Not specified
  • Purpose: Educating HCPs to increase awareness and enable appropriate and early patient identification by closing knowledge gaps in disease epidemiology, pathophysiology, diagnosis, and emerging treatment paradigms. 
  • Eligibility: All entities with a mission related to healthcare professional education and/or healthcare improvement eligible to apply.
NIH – NCI Research Specialist (Clinician Scientist) Award (R50 Clinical Trial Not Allowed)
  • Due: Rolling through October 2023: next review date September 6, 2022 (LOI)
  • Funding: Varies
  • Project period: Up to 5 years
  • Purpose: To encourage development of research career opportunities for exceptional clinician scientists who want to continue participation in the NCI clinical trials networks through leadership in various aspects of clinical trials. 
  • Eligibility: Clinician scientists with a clinical degree (M.D., D.O., D.D.S., D.M.D., O.D., D.C., PharmD., N.D., D.V.M.) and active license, actively practicing in an oncology clinical setting, and individuals with a Ph.D. or other doctoral degree that have direct contact with patients or healthy subjects in clinical disciplines such as clinical psychology, nursing, clinical genetics, speech-language pathology, audiology, or rehabilitation are eligible.
NIH – Stimulating Access to Research in Residency Transition Scholar (STARRTS) K38 Career Development
  • Due: Rolling through October 2024: next review deadline October 13, 2022
  • Funding: Varies
  • Project period: Up to 2 years
  • Purpose: To support Transition Scholars by providing grantees with continued research and career development opportunities in basic, clinical and/or translational research thereby enhancing the potential to accelerate their transition to independent research careers. 
  • Eligibility: Health professionals who will have successfully completed the Stimulating Access to Research in Residency (StARR) Program, Stimulating Access to Research in Residency (StARR) (R38 Independent Clinical Trial Not Allowed) and started a clinical fellowship or early career faculty position (as instructor or assistant professor for less than 40 months at the time of submission or resubmission) by the time of the K38 award may apply.
Pediatric Dermatology Research Alliance (PeDRA) Study Support Grants
  • Due: Rolling Through the end of the calendar year.
  • Funding: Up to $4,000
  • Project Period: 6 months.
  • Purpose: To fund statistical and/or publication support of active PeDRA Studies
  • Eligibility: Study Support Grants are available to PeDRA Members only.  Please login or join PeDRA to access this content.
Pfizer Global Medical Grants – Visiting Professorship Program
  • Due: Rolling
  • Funding: Varies
  • Project period: Not specified
  • Purpose: To provide financial support for host organizations to coordinate educational exchanges so that healthcare practitioners, researchers and patients can benefit from the knowledge and on-site presence of distinguished medical experts. Application review dates: July 15, 2022 & October 17, 2022
  • Eligibility: Eligibility criteria for visiting professorship programs vary. Check eligibility requirements.
Alexander von Humboldt Research Foundation – Humboldt Research Fellowship
  • Due: Rolling until July
  • Funding: €3,170 monthly; €2,670 monthly (postdoctoral)
  • Project period: 6 – 18 months; 6 – 24 months (postdoctoral)
  • Purpose: To support research by scientists at any stage of their career in collaboration with a host at a German research institution of choice. Further financial support may be available.
  • Eligibility: Eligible candidates must be postdoctorals (within 6 months of completing terminal degree to those who have completed their degree within the last 4 years), and established scientists who have completed their terminal degree within the last 12 years. November will be the final review cycle for 2022.
Immune Tolerance NetworkRequest for Applications
  • Due: Open; Concept Proposals accepted year-round
    • Full applications accepted by invitation
  • Funding: Not specified
  • Project period: Not specified
  • Purpose: To fund research in 1) allergy & asthma, 2) autoimmune diseases, 3) kidney & liver transplantation, and 4) assays & biomarkers.
  • Note: ITN does not accept proposals for non-human or preclinical studies.
NIH – Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00)
MOSAIC K99/R00 – Independent Clinical Trial Not Allowed
MOSAIC K99/R00 – Independent Clinical Trial Required
MOSAIC K99/R00 – Independent Basic Experimental Studies with Humans Required (BESH)
  • Due: Rolling
  • Funding: Varies
  • Project period: Up to 5 years (2 years K99; 3 years R00)
  • Purpose: To support early career, independent investigators from diverse backgrounds conducting research related to NIH mission.
  • Eligibility: Candidates from underrepresented racial and ethnic groups as well as individuals with disabilities, women and individuals from disadvantaged backgrounds are encouraged to apply. Open to early career candidates working with a mentor.
NIH/FIC/NCI – International Research Scientist Development Award (IRSDA) (K01) Independent Clinical Trial Not Allowed
  • Due: Standard March dates.
  • Funding: Up to $150,000 per year
  • Project period: Up to 5 years
  • Purpose: To provide protected time for conducting postdoctoral mentored global health research in low-  and middle-income countries to strengthen global health research.
NIH/NHLBI – Programs to Increase Diversity Among Individuals Engaged in Health-Related Research (PRIDE)
  • Due: Pre-applications considered on a rolling basis
    • Full applications accepted by invitation
  • Funding: All-expense-paid Summer Institute Program via NHLBI
  • Project period: One summer
  • Purpose: To provide mentoring to junior investigators and tr
  • ansitioning postdoctoral fellows from underrepresented backgrounds. Distinct programs offered across multiple campuses.
  • Eligibility: 1) U.S. citizen or permanent resident; 2) holds doctoral degree (e.g., PhD, MD, DO, DVM); 3) from a group that is underrepresented in biomedical or health sciences; 4) research focus on heart, lung, blood or sleep (HLBS) disorders; and 5) hold formal faculty appointment before start of Summer Institute Program.
NIH/NHLBI – Mentored Career Development Award to Promote Faculty Diversity in Biomedical Research

K01 Independent Clinical Trial Required
K01 Independent Clinical Trial Not Allowed

  • Due: Standard October and February Dates.
  • Funding: Up to $150,000 per year
  • Project period: Up to 5 years
  • Purpose: To promote diversity in the biomedical, behavioral, clinical and social sciences workforce.
NIH/NIAID – Primary Caregiver Technical Assistance Supplements (PCTAS)
  • Due: Rolling; submit 30 days before targetted review date
    • Anticipated review in Nov, Feb, Apr, May
  • Funding: Up to $50,000 for technician salary
  • Project period: Up to 2 years
  • Purpose: To maintain productivity for a postdoc who is caring for children or ailing relative. Funds to be used for personnel to assist postdoc.
  • Eligibility: Lab PI must have NIAID-funded P/U/R grant with at least 1 year remaining.
NIH – Administrative Supplements to Promote Research Continuity and Retention of NIH Mentored Career Development (K) Award Recipients and Scholars
  • Due: Varies by awarding IC
  • Funding: Up to $50,000 direct costs
  • Project period: Up to 1 year
  • Purpose: To sustain mentored investigator’s research during critical life events. Applications may be submitted in advance of a known event or after the fact.
  • Note: Funds can be used for staff, supplies, or equipment within the original scope of research for the currently-funded grant period.
NIH – International Research Scientist Development Award (IRSDA)(K01)

International Research Scientist Development Award (IRSDA) (K01) (No Clinical Trial)
International Research Scientist Development Award (IRSDA) (K01) (Clinical Trial Required)

  • Due:  March 9, 2022; March 9, 2023
  • Funding: Unspecified
  • Project Period: Up to 5 years
  • Purpose: To provide support and protected time to for an intensive, mentored research career development experience in a low- or middle- income country for early career scientist.
  • Eligibility: Award intended for advanced postdoctoral U.S. research scientist and recently appointed early career faculty (up to 2 years past terminal degree).
NIH – Research Supplements to Promote Diversity in Health-Related Research
  • Due: Varies by awarding IC
  • Funding: Not specified
  • Project period: Within project period of active grant
  • Purpose: To enhance the diversity of the research workforce by recruiting and supporting students, postdocs, and eligible investigators from diverse backgrounds.
  • Note: As of January 2021, NIGMS accepts applications to support faculty-level investigators developing independent research careers. Faculty who haven’t previously served as program director or principal investigator on NIH research grant, individual research career development award, or project leader of a NIH award subproject.
NIH – Administrative Supplement for Continuity of Biomedical and Behavioral Research Among First-Time Recipients of NIH Research Project Grant Awards
  • Due: Varies by awarding IC
  • Funding: Up to $50,000 direct costs
  • Project period: Up to 1 year
  • Purpose: To enhance the retention of investigators facing critical life events who are approaching the first renewal of their first independent grant or to a second new NIH grant.
NIH – Notice of Special Interest: Research Supplements to Promote Re-Entry and Re-integration into Health-Related Research Careers (Admin Supp – Clinical Trial Not Allowed)
  • Due: Varies by awarding IC
  • Funding: Not specified
  • Project period: Not specified
  • Purpose: To provide support for mentored research training for individuals to re-enter or re-integrate into an active research career, after an interruption for family responsibilities or other qualifying circumstance.
NIH – Notice of Special Interest: Administrative Supplements for Research on Sexual and Gender Minority (SGM) Populations (Admin Supp Clinical Trial Optional)
  • Due: January 31, 2022; January 31, 2023; January 31, 2024
  • Funding: Up to $100,000
  • Project period: 1 year
  • Purpose: To provide funding for expansion of existing research to incorporate sexual and gender minority (SGM) populations or SGM-relevant research questions.
NIH –Notice of Special Interest: Secondary Analysis of Posttraumatic Psychopathology Data
  • Due: February 5, 2022 and subsequent receipt dates through January 8, 2025
  • Funding: Varies
  • Project Period: Varies
  • Purpose: To support research that analyzes existing and accumulating data to help in refining phenotypes of posttraumatic psychopathology(ies), markers of onset and change, and risk, detection and to identify potential prevention and treatment targets.
  • Eligibility: Early career and established investigators encouraged to apply.
NIH –Notice of Special Interest: Clinical Relevance of the Linkage between Environmental Toxicant Exposures and Alzheimer’s Disease and Related Dementias (R01 Clinical Trial Not Allowed)
  • Due: January 31, 2023 for FY 2023; and January 31, 2024 for FY 2024
  • Funding: Up to $500,000 per year
  • Purpose: To support mechanistic and early translational research focused on rigorous, in-depth examination of the potential interactions of environmental toxins with genetic and no-genetic molecular targets known to influence Alzheimer’s Disease and Alzheimer’s Disease Related Dementias.
  • Eligibility: Scientists at all levels eligible to apply.
NIH/NIDDK – Administrative Supplements to Support Emerging Physician-Scientists to Develop Research Expertise in Diabetes, Endocrinology and Metabolic Diseases
  • Due: February 3, 2023 for awards in June to August 2023
  • Funding: Up to $100,000 salary support, and $25,000 supplies
  • Project period: 2 years
  • Purpose: To support advanced research opportunities for physician-scientists holding the MD or equivalent or MD/PhD degrees, and who are early in their research careers.
  • Eligibility Notes: PD/PIs of an active R01, U01, U54, R18, RC2, DP1 or P01 award from NIDDK’s DDEMD are eligible to apply if they have at least 2 years of support remaining in the current project period.
NIH – Notice of Special Interest: Secondary Analysis of Posttraumatic Psychopathology Data
  • Due: February 5, 2022 and subsequent receipt dates through January 8, 2025
  • Funding: Varies
  • Project period: Varies
  • Purpose: To support research that analyzes existing and accumulating data to help in refining phenotypes of posttraumatic psychopathology(ies), markers of onset and change, and risk, detection and to identify potential prevention and treatment targets.
  • Eligibility: Early career and established investigators encouraged to apply.
NIH – BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Not Allowed)
  • Due: February 10, 2022; June 8, 2022: October 11, 2022
  • Project period: 5 years maximum
  • Purpose: To increase workforce diversity in the neuroscience workforce and maintain a strong cohort of new and talented, NIH-supported, independent investigators from diverse backgrounds in BRAIN Initiative research areas.
  • Eligibility: Applicants must have 5 years or less of postdoctoral research experience, be a citizen, non-citizen national or permanent resident of the United States and be a member of an underrepresented ethnic or minority group in the health-related sciences field.
NIH/NIMH – NIMH Instrumentation Program (S10 Clinical Trial Not Allowed)
  • Due dates: October 7, 2022; October 10, 2023; October 9, 2024
NIH – Temporary Eligibility Extensions Due to COVID-19 Pandemic
National Institutes of HealthCareer Development (K) Awards
  • New Applications due: annually on February 12, June 12, October 12
  • Renewal/Revision/Resubmission: annually on March 12, July 12, November 12
National Institutes of Health – Individual Fellowship (F) Awards
  • All Types Due: annually on April 8, August 8, December 8
National Institutes of Health – Stephen I. Katz Early Stage Investigator Research Project Grant

R01 Clinical Trial Not Allowed
(R01 Basic Experimental Studies with Humans Required)



November

December

HIV Medicine Association – HIV Clinical Fellowship Program
  • Due: December 12, 2022
  • Funding: PGY-4 level (up to $73,961) prorated
  • Project period: 1 year
  • Purpose: To support MDs and DOs who would like to gain HIV clinical experience working with medically underserved patient populations. Full-time or half-time fellowships available.
  • Eligibility: Board eligible MDs and DOs (for their residency training specialty by commencement of fellowship) who are U.S. residents and have not completed an infectious disease fellowship program or are not currently enrolled in one are eligible.
Alex’s Lemonade Stand Foundation for Childhood Cancer – 2023 Young Investigator Grant
  • Due: December 12, 2022
  • Funding: Up to $180,000
  • Project period: Over 3 years
  • Purpose: To support early career researcher strategies that will lead to the development of therapies that will prevent the transition from pre-malignancy to overt hematologic malignancy in patients with RUNX1-FPD.
  • Eligibility: Applicants must have an MD, PhD, or MD/PhD (DO, MBBS or equivalent) and be within five years of their first faculty appointment as an Assistant Professor or equivalent tenure-track position. If at the Instructor level, the applicant must submit a letter of support from their mentor at the sponsoring institution. Applicant’s institution must be in the US or Canada.
U.S.-Israel Binational Science Foundation (BSF) – Professor Rahamimoff Travel Grants for Young Scientists
  • Due: December 13, 2022
  • Funding: $6,000
  • Project period: 1 year
  • Purpose: To support early career scientists’ travel to a higher education or research facility in the U.S. (for Israelis) or Israel (for U.S) students for a maximum period of two months. Two annual calls support 10 grants each.
  • Eligibility: Open to PhD students conducting research that requires facilities or expertise unavailable in their home country.
American Association for Cancer Research (AACR) – AACR Immuno-Oncology Research Fellowships
  • Due: December 14, 2022
  • Funding: $120,000
  • Project period: 2 years
  • Purpose: To help postdoctoral and clinical research fellows establish successful careers in the immune-oncology research field.
  • Eligibility: Applicants must hold a mentored research position as a postdoctoral fellow, clinical research fellow or equivalent at an academic, medical ore research institution and have completed their most recent doctoral degree or medical residency within the past five years.
Research to Prevent Blindness – RPB Stein Innovation Award
  • Due: December 15, 2022 (nominations); January 10 full applications due
  • Funding: $300,000 (2 payments)
  • Project period: Not specified
  • Purpose: To provide seed money for ophthalmology faculty conducting high-risk/high-reward innovative, cutting-edge research. The second payment is contingent upon approval of a 14-month substantive progress report.
  • Eligibility: Candidates at any US, higher-ed institution may apply. MDs, PhDs, or MD/PhDs with an academic position of Associate Professor through full Professor may be nominated by their full-time chair.
Research to Prevent Blindness – RPB International Research Collaborators Award
  • Due: December 15, 2022 (nominations due; January 10 full application)
  • Funding: Up to $75,000
  • Project period:  Not specified
  • Purpose: To promote international research collaborations between researchers in the U.S. and abroad to accelerate the development of treatments for blinding disorders affecting large populations worldwide.
  • Eligibility: The award is available to researchers from any institution of higher education in the U.S. Only one nomination per department per school will be considered.
Research to Prevent Blindness – RPB/LCIF Low Vision Research Award
  • Due: December 15, 2022 (nominations due; January 10 full application)
  • Funding: Up to $300,000
  • Project period:  Up to 3 years
  • Purpose: To provide seed funding for high-risk / high-gain, innovative, cutting-edge research which demonstrates out-of-the-box thinking focused on how the visual system and brain responds to severe and chronic visual loss) which demonstrates.
  • Eligibility: Researchers from any institution of higher education in the U.S., currently holding a primary academic position as Assistant Professor through full Professor, are eligible.
Research to Prevent Blindness – RPB Career Development Award
  • Due: December 15, 2022 (nominations due; January 10 full application)
  • Funding: Up to $350,000
  • Project period:  Up to 4 years
  • Purpose: Provides funding for RPB-supported ophthalmology chairs to support promising early career ophthalmology faculty who have demonstrated potential for a career as an independent researcher.
  • Eligibility: Candidates (MDs, PhDs, or MD/PhDs) must have primary appointments in ophthalmology with academic positions up to and including Assistant Professor within three 3 years of the application deadline.  Secondary appointments recommended for PhDs. 50% protected time required, 60% preferred.
American Academy of Facial Plastic and Reconstructive Surgery, Inc. – Leslie Bernstein Grants Program
Bernstein Grant
Investigator Development Grant
Resident Research Grant
  • Due: December 15, 2022
  • Funding: Up to $25,000
  • Project period: Up to 3 years
  • Purpose: To support and encourage original work by AAFPRS early career members conducting research that aims to advance the field of facial plastic and reconstructive surgery.
  • Eligibility: Candidates must be an MD residing in the U.S. or Canada.
Elsa U. Pardee Foundation – Research Grant
  • Due: December 15, 2022
  • Funding: Not specified
  • Project period: 1 year
  • Purpose: To support creative, unique and innovative studies focused on identifying new treatments or cures for cancer by new cancer researchers or established researchers with new approaches.
  • Eligibility: Early career scientists or established scientist with new ideas in North America are eligible to apply.
Cystic Fibrosis Foundation – CFF/NIH R01/R21-Unfunded Award
  • Due: December 15, 2022
  • Funding: Up to $125,000 per year
  • Project period: Up to two years
  • Purpose: To provide funding for CF-related research projects that have been submitted to and approved by NIH or governmental funding agencies in other countries but are not yet funded.
  • Eligibility: Applications must fall within the upper 40th percentile of NIH R01/R21 submissions within 12 months of applying for CFF bridge funding. The original R01/R21 grant must be relevant to advancing the Cystic Fibrosis Foundation’s mission. Other eligibility factors may apply.
American Lung Association – Public Policy Research Award
  • Due: December 15, 2022
  • Funding: Up to $50,000 per year
  • Project period: Up to 2 years
  • Purpose: To support research on and evaluation of existing public policy and programs, and projects that promote innovative ideas and provide evidence for the development of new policies impacting lung health.
  • Eligibility: U.S. citizenship or foreign national status (check eligibility) required. Applicants should hold a doctoral or relevant terminal degree and have a faculty appointment or equivalent, and on track to pursue public policy research (including economics, political science, sociology, law and related disciplines).
American Lung Association Dalsemer Award
  • Due: December 15, 2022
  • Funding: $50,000 per year
  • Project period: Up to 2 years
  • Purpose: A mentored award to provide seed money to early career investigators on the path to independence in research focused on the mechanisms and biology of interstitial lung disease.
  • Eligibility: U.S. citizenship or foreign national status (check eligibility) required. Applicants should be on track to pursue a career in lung disease research with an experienced mentor, hold a doctoral degree and have a faculty appointment or equivalent at a recognized academic or other not-for-profit institution by time of application. MDs should have completed two years of post-doctoral research training by award start date.
American Lung Association – Allergic Respiratory Diseases Award
  • Due: December 15, 2022
  • Funding: $75,000 per year
  • Project period: Up to 2 years
  • Purpose: To support early career faculty conducting research in the Clinical Allergy and Immunology field of study working to advance the understanding of allergic respiratory disease.
  • Eligibility: Applicants should hold a doctoral degree and primary faculty appointment in a Clinical Allergy and Immunology division/section, be independent investigators involved in related research. Priority will be given to those below the rank of associate professor who have not received more than one R award. U.S. citizenship or permanent residency and certain visa immigration status required.
American Lung AssociationCatalyst Award
  • Due: December 15, 2022
  • Funding: $50,000 per year
  • Project period: Up to 2 years
  • Purpose: To support outstanding investigators on the path to independence for research targeting the mechanisms of lung disease and general lung biology. Preference given to projects that are novel, innovative in design/approach or that use modern technologies or a multidisciplinary approach.
  • Eligibility: U.S. citizenship or foreign nationals (check eligibility), or temporary worker with extraordinary abilities in the sciences are eligible. Early career faculty (or equivalent) on track to pursue a career in lung health research with a mentor, with a doctoral degree required. MDs need 2 years of post-doctoral research training by award start date.
Orthopaedic Research & Education Foundation (OREF) OREF/Goldberg Arthritis Research Grant
  • Due: December 15, 2022
  • Funding: $50,000
  • Project period: 1 year
  • Purpose: To support investigator-initiated research proposals aimed at treating arthritis with an emphasis on arthroplasty by new faculty investigators.
  • Eligibility:  PIs must be new investigators (no R01 awardees or equivalent); MDs licensed to practice medicine in the U.S.; both MD and PhD applicants must hold a faculty appointment in an orthopaedic department.
Orthopaedic Research & Education Foundation (OREF) OREF/ASES/Rockwood
  • Due: December 15, 2022
  • Funding: $50,000
  • Project period:  1 year
  • Purpose: To encourage new investigators by providing seed and start-up funding for promising clinical research projects in shoulder care.
  • Eligibility:  An orthopaedic surgeon principal investigator (PI) must be licensed to practice and working in an institution in the U.S.  A PhD may serve as the PI and must hold a faculty appointment in an orthopaedic department at an institution in the U.S. Membership in the American Shoulder and Elbow Surgeons required. PI must be a new investigator.
Challenge.gov – NIH Long COVID Computational Challenge (L3C)
  • Due: Open until December 15, 2022
  • Funding: $500,000
  • Project period: Not specified
  • Purpose: To spur and reward the development of AI/ML models to identify which patients infected with SARS-CoV-2 are likely to develop PASC/Long COVID.
  • Eligibility: This challenge is intended to for U.S.-based entities: individual investigators, teams and public or private organizations. Non-US citizens or non-permanent citizens may only apply as part of a group that meets U.S. citizenship criteria.
American Lung AssociationInnovation Award
  • Due: December 16, 2021
  • Funding: $75,000 per year
  • Project period: Up to 2 years
  • Purpose: To support highly promising investigators with outstanding track records of accomplishment who have the potential to advance the field of lung disease science.
  • Eligibility: Investigators who have shown evidence of prior excellence and productivity in the early stages of their career who must have held a K or R type award within 3 years prior to applying for the ALA Innovation Award.
Sanofi – Sanofi iDEA-iTech Awards North America 2023
  • Due: December 16, 2022 (Pre-proposals)
  • Funding: $150,000
  • Project period: 1 year
  • Purpose: To promote innovation through collaborations, with a focus on cutting-edge digital and data tools and new technologies for R&D applications.
  • Eligibility: Open to academic institutions across North America and new start-ups coming through these institutions. Pre-proposals must be validated by the applicant’s institution’s Tech Transfer Office.
Alex’s Lemonade Stand Foundation WITH the RUNX1 Research Program  – 2023 RRP-ALSF Early Career Investigator (ECI) Grant Program
  • Due: December 21, 2023
  • Funding: Up to $180,000
  • Project period: 3 years
  • Purpose: To fund research leading to the development of therapies to prevent the transition from pre-leukemia to leukemia for RUNX1-FPD.
  • Eligibility: Applicant institutions must be based in the United States or Canada.  Applicants need not be United States citizens. Funds must be granted to nonprofit institutions or organizations. Applicants must have an MD, PhD, or MD/PhD (DO, MBBS or equivalent) and be within five years of their first faculty appointment as an Assistant Professor or equivalent tenure-track position. Associate and Full Professors are ineligible. If at the Instructor level, the applicant must submit a letter of support from their mentor at the sponsoring institution
American Society for Clinical Oncology – Young Investigator Awards (Special Competitions)
Cystic Fibrosis Foundation – CFF/NIH K-Boost Award
  • Due: Rolling deadline through December 31,2022
  • Funding: Up to $50,000 per year
  • Project period: Up to 5 years
  • Purpose: To provide supplemental funding to qualified and promising scientists early in their faculty careers who have obtained K funding (e.g.: K08, K23, K25) from the NIH in areas that reflect the CFF research priority areas.
  • Eligibility: Applicants must be independent investigators who are U.S. citizens or U.S. permanent residents, with an active NIH K award with at least twelve months of funding left at the time of applying for CFF funding.

January

American Epilepsy Society – Sergievsky Award for Epilepsy Health Equity and Diversity
  • Due: January 12, 2023
  • Funding: $75,000 per year
  • Project period: 2 years
  • Purpose: To support early career physicians and scientists in underrepresented racial or ethnic groups (with preference for those who are Black or African American), and/or who are researching issues affecting medically underserved individuals with epilepsy or seizures or related aspects of health equity.
  • Eligibility: AES membership required. Applicants should hold an MD, DO, PhD, PharmD, DNP, or other professional degree within a related track, be a clinical fellow, research fellow, clinical instructor, or clinician investigator or assistant professor for clinicians or equivalent levels of career for nonphysicians in neuropsychology, psychology, pharmacology, nursing, or research. 50% protected time required.
American Epilepsy Society – Postdoctoral Fellowship Award
  • Due: January 12, 2023
  • Funding: Up to $50,000
  • Project period: 1 year
  • Purpose: To support postdoctoral trainees conducting basic, translational, or clinical research into the cause, treatment, and consequences of epilepsy, seizures, and related disorders, under the guidance of a mentor with expertise in epilepsy research.
  • Eligibility: Applicants should hold an MD, DO, PhD, ScD, PharmD, RN or equivalent degree, be a postdoctoral fellow at an eligible institution before start date. Note: Researchers with non-independent faculty positions such as Instructor, Adjunct Professor, Research Assistant Professor, or non-tenure track Assistant Professor may apply if working under the supervision of a PI but are strongly encouraged to outline a clear plan for transition to independence.
American Epilepsy Society – Junior Investigator Research Award
  • Due: January 12, 2023
  • Funding: Up to $50,000
  • Project period: 1 year
  • Purpose: To support early career investigators in conducting research to facilitate the successful obtainment of future competitive grants from NIH or other sources.
  • Eligibility: Applicants should hold a MD, DO, PhD, ScD, RN, or equivalent degree, faculty appointment of Assistant Professor or equivalent at a university, medical school, research institution, or medical center, not currently hold or have previously received a larger, multi-year grant, K or R award or equivalent. Note: Researchers with other early faculty appointments (such as Instructor, Adjunct Track, etc.) may apply but are strongly encouraged to provide a letter of support from their department chair.
American Epilepsy Society – Research and Training Fellowship for Clinicians
  • Due: January 12, 2023
  • Funding: Up to $50,000
  • Project period: 1 year
  • Purpose: To provide mentored support for clinical fellows or clinical faculty who intend to pursue a career in epilepsy research including basic, translational and clinical research focused on epilepsy, seizures and other related disorders.
  • Eligibility: Applicants should hold a MD, DO, PhD, ScD, DO, PharmD or equivalent degree in a related discipline, be a clinical or postdoctoral fellow, or newly appointed clinical faculty member within 5 years of first full-time appointment by start of project. 50% protected time required. Mentor with epilepsy-related research expertise is required.
American Epilepsy Society – Pediatric Research and Training Fellowship for Clinicians
  • Due: January 12, 2023
  • Funding: Up to $50,000
  • Project period: 1 year
  • Purpose: Sponsored by the Pediatric Epilepsy Research Foundation and American Epilepsy Society to provide mentored support for a highly-scored proposal focused on pediatric epilepsy research.
  • Eligibility: Applicants should hold a MD, DO, PhD, ScD, DO, PharmD or equivalent degree in a related discipline, be a clinical or postdoctoral fellow, or newly appointed clinical faculty member within 5 years of first full-time appointment by start of project. 50% protected time required.
American Epilepsy Society – Epilepsy Study Consortium Mini-Grant
  • Due: January 12, 2023
  • Funding: Up to $22,000
  • Project period: 6 months to 1 year
  • Purpose: To support a mentored- research project in anti-epileptic drug therapy by an epilepsy fellow.
  • Eligibility: Applicants must hold an MD, DO, PhD, ScD, PharmD, RN or equivalent degree, be either accepted or enrolled (in the first year of a 2-yr fellowship), and have a qualified mentor with epilepsy-related research experience.
Doris Duke Charitable Foundation – Physician Scientist Fellowship
  • Due: January 13, 2023
  • Funding: Up to $110,000/year
  • Project period: 2 years
  • Purpose: To support individuals pursuing clinical research careers, whose projects aim to address highly significant research questions and facilitate career advancement.
  • Eligibility:  Applicants must have a clinical subspecialty fellowship with a completion date between June 30, 2022 and July 1, 2024, not have any type of faculty appointment, have completed the majority of the clinical training portion of the fellowship by the award start date. 75% protected time required.
Radiological Society of North America (RSNA) – Research Seed Grant
  • Due: January 18, 2023
  • Funding: $60,000
  • Project period: 1 year
  • Purpose: To support investigators in defining objectives and test hypotheses in preparation for larger grant submissions.
  • Eligibility: Any full-time faculty RSNA member in a radiology, radiation oncology or nuclear medicine department at an educational institution who does not have a grant totaling more than $60,000 in a single year. Advanced training must have been completed; certification by the American Board of Radiology or The Royal College of Physicians and Surgeons of Canada or be on track for certification.
 Radiological Society of North America (RSNA) – Research Scholar Grant
  • Due: January 18, 2023
  • Funding: $100,000 per year
  • Project period: 2 years
  • Purpose: To help early career investigators collect preliminary data needed to obtain larger grants and establish successful research careers in the radiologic sciences.
  • Eligibility: Applicants must hold (within 8 years) a full-time faculty position in a department of radiology, radiation oncology or nuclear medicine at a North American educational institution. Completed training required, and applicant must have certification by either the American Board of Radiology, the Royal College of Physicians and Surgeons of Canada or be on track for certification. Applicants may not have a grant totaling more than $60,000 in one year at time of application. Membership required. International applicants are required to be certified in their country.
NIH – Development of Biomarkers or Biomarker Signatures for Neurological and Neuromuscular Disorders (R61/R33 Clinical Trial Optional)
  • Due: January 22, 2023(LOI)
  • Funding: Not specified
  • Project period: Up to 5 years combined for R61 and R33 phases
  • Purpose: To provide support for investigators to conduct proof of concept biomarker discovery and development studies followed by preliminary clinical validation to evaluate if the candidate biomarker or biomarker signature may be fit-for-purpose for use in clinical trials or clinical practice.
  • Eligibility: PIs at all levels eligible to apply.
NIH/NCI – Administrative Supplements to Support Cancer Disparity Collaborative Research (Clinical Trial Optional)
  • Due: January 23, 2023
  • Funding: Up to $150,000
  • Project period: Up to 1 year
  • Purpose: To accelerate and strengthen multi-disciplinary cancer disparities research in wide ranging areas by supporting new cancer disparities research among investigators new to cancer-disparities research.
  • Eligibility: Investigators must hold an active grant or cooperative agreement, and the research proposed in the supplement must be accomplished within the competitive segment of the active award.

February

NIH/NCI – NCI Research Specialist (Clinician Scientist) Award (R50 Clinical Trial Not Allowed)
  • Due: February 7, 2023
  • Funding: Unspecified
  • Project period: Up to 1 year
  • Purpose: To support clinician scientists who continue to participate in NCI clinical trials networks through leadership in the 1) development of national clinical trials, 2) implementation of NCI clinical trials in their institutions, and 3) national service to the NCI clinical trials networks through participation in the scientific review committees, monitoring committees, and other activities, but not serve as principal investigators of research project grants.
  • Eligibility: Applicants must be clinician scientists (M.D., D.O., D.D.S., D.M.D., O.D., D.C., PharmD., N.D., D.V.M.), with active licensure, actively practicing in an oncology clinical setting. PhDs or other doctoral degrees with direct patient or healthy subjects contact in clinical disciplines such as clinical psychology, nursing, clinical genetics, speech-language pathology, audiology, or rehabilitation are also eligible.
Wellcome – Early Career Award
  • Due: February 21, 2023
  • Funding: £400,000
  • Project Period: Up to 5 years
  • Purpose: To provide funding to aid the transition of early career investigators to independent research careers.
  • Eligibility: Applicants must have a PhD or equivalent or at least four years of equivalent research experience in the humanities and sciences, but no more than three years of postdoctoral experience.

Want to live on the Edge?

Register


Join the conversation

Your email address will not be published. Required fields are marked *


Saving subscription status...

11 Comments

You May Also Like